on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has filed Form 8.3 regarding Mural Oncology plc. As of September 30, 2025, Vanguard holds a stake of 454,712 ordinary shares, representing 2.63% of Mural Oncology's $0.01 shares. This disclosure follows Rule 8.3 of the Irish Takeover Panel Act, 1997.
The document indicates that on September 30, Vanguard conducted a purchase of 16 shares and a sale of 191,872 shares, both at a price of 2.07 USD per share. No dealings in cash-settled or stock-settled derivatives were reported. Vanguard confirms no agreements or understandings regarding options or derivatives relating to Mural Oncology securities.
The filing confirms compliance with regulations requiring disclosure of interests exceeding 1%. No additional parties are involved, and no supplementary forms are attached to the disclosure.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news